The pharmacokinetic and pharmacodynamic interaction of clopidogrel and cilostazol in relation to CYP2C19 and CYP3A5 genotypes.
about
Pharmacogenetics of drug-drug interaction and drug-drug-gene interaction: a systematic review on CYP2C9, CYP2C19 and CYP2D6.Effect of cilostazol on platelet reactivity among patients with peripheral artery disease on clopidogrel therapy.Association between CYP2C19 genotype and the additional effect of cilostazol to clopidogrel resistance in neuroendovascular therapy.
P2860
The pharmacokinetic and pharmacodynamic interaction of clopidogrel and cilostazol in relation to CYP2C19 and CYP3A5 genotypes.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
The pharmacokinetic and pharma ...... CYP2C19 and CYP3A5 genotypes.
@en
type
label
The pharmacokinetic and pharma ...... CYP2C19 and CYP3A5 genotypes.
@en
prefLabel
The pharmacokinetic and pharma ...... CYP2C19 and CYP3A5 genotypes.
@en
P2093
P2860
P356
P1476
The pharmacokinetic and pharma ...... CYP2C19 and CYP3A5 genotypes.
@en
P2093
Dong-Hyun Kim
Eun-Young Kim
Ho-Sook Kim
Jae-Gook Shin
Minkyung Oh
Younghae Lim
P2860
P304
P356
10.1111/BCP.12794
P407
P577
2015-10-01T00:00:00Z